Alex de Winter
Managing Director at GE Ventures
Alex de Winter is a managing director at GE Ventures, where he has led investments in Labcyte, RainDance Technologies, Syapse, and Veracyte. Alex joined GE Ventures from Mohr Davidow Ventures, where he served as a board observer for CardioDx, Corventis, Crescendo Bioscience, DVS Sciences, and Personalis.
He started his career as a research scientist with 454 Life Sciences and Pacific Biosciences. Alex has an MBA from UC Berkeley, a Ph.D. in chemistry from Stanford, and graduated from Amherst College.